A detailed history of Braun Bostich & Associates Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Braun Bostich & Associates Inc. holds 2,197 shares of EW stock, worth $143,859. This represents 0.15% of its overall portfolio holdings.

Number of Shares
2,197
Previous 3,586 38.73%
Holding current value
$143,859
Previous $342,000 40.94%
% of portfolio
0.15%
Previous 0.29%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$84.3 - $94.31 $117,092 - $130,996
-1,389 Reduced 38.73%
2,197 $202,000
Q1 2024

Apr 29, 2024

SELL
$72.54 - $95.56 $105,980 - $139,613
-1,461 Reduced 28.95%
3,586 $342,000
Q4 2023

Jan 29, 2024

BUY
$61.71 - $77.76 $103,302 - $130,170
1,674 Added 49.63%
5,047 $384,000
Q3 2023

Nov 01, 2023

BUY
$69.28 - $93.38 $233,681 - $314,970
3,373 New
3,373 $233,000
Q2 2022

Aug 16, 2022

SELL
$86.5 - $128.27 $147,655 - $218,956
-1,707 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$101.96 - $128.34 $174,045 - $219,076
1,707 New
1,707 $201,000
Q4 2020

Feb 16, 2021

SELL
$71.69 - $91.23 $255,646 - $325,326
-3,566 Closed
0 $0
Q3 2020

Oct 09, 2020

BUY
$67.19 - $87.44 $21,299 - $27,718
317 Added 9.76%
3,566 $285,000
Q2 2020

Aug 13, 2020

BUY
$57.54 - $76.95 $125,494 - $167,827
2,181 Added 204.21%
3,249 $225,000
Q3 2019

Nov 14, 2019

SELL
$61.55 - $75.43 $23,942 - $29,342
-389 Reduced 26.7%
1,068 $235,000
Q2 2019

Aug 14, 2019

SELL
$55.74 - $64.41 $87,623 - $101,252
-1,572 Reduced 51.9%
1,457 $269,000
Q1 2019

May 09, 2019

SELL
$47.89 - $64.05 $32,756 - $43,810
-684 Reduced 18.42%
3,029 $580,000
Q4 2018

Feb 08, 2019

BUY
$46.41 - $56.94 $157,747 - $193,539
3,399 Added 1082.48%
3,713 $569,000
Q3 2018

Nov 14, 2018

BUY
$45.7 - $58.03 $14,349 - $18,221
314 New
314 $55,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Braun Bostich & Associates Inc. Portfolio

Follow Braun Bostich & Associates Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Braun Bostich & Associates Inc., based on Form 13F filings with the SEC.

News

Stay updated on Braun Bostich & Associates Inc. with notifications on news.